Menu

Can celecoxib be used to relieve symptoms of osteoarthritis?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Can celecoxib be used to relieve symptoms of osteoarthritis? (Celebrex) is indicated for the relief of the signs and symptoms of osteoarthritis, the relief of the signs and symptoms of rheumatoid arthritis in adults, and the treatment of acute pain in adults.

The mechanism of action of celecoxib is to inhibit COX to prevent arachidonic acid from synthesizing prostaglandins and inhibit inflammation. The initial phase of inflammation induces COX-2 production, which leads to the synthesis and accumulation of inflammatory prostaglandins, especially prostaglandin E2, which can cause inflammation, edema, and pain. Celecoxib can achieve anti-inflammatory, analgesic and antipyretic effects by inhibiting the production of inflammatory prostaglandins in COX-2 tissues.

The potential benefits and risks of celecoxib and other treatment options should be carefully considered before deciding to use celecoxib. Use the lowest effective dose for the shortest treatment duration based on each patient's treatment goals.

Celecoxib is used for osteoarthritis and rheumatoid arthritis, and the lowest dose of this product is determined based on individual circumstances. The time of eating has no effect on the dosage.

Celecoxib for Osteoarthritis: The recommended dose of celecoxib to relieve the signs and symptoms of osteoarthritis is 200 mg orally once daily or 100 mg orally twice daily.

Celecoxib for Rheumatoid Arthritis: The recommended dose of celecoxib to relieve the signs and symptoms of rheumatoid arthritis is 100 mg to 200 mg twice daily.

Celecoxib for acute pain: The recommended dose is 400 mg as the first dose on the first day, and an additional 200 mg if necessary; thereafter, 200 mg twice daily as needed.

Trials in Special Populations (Celebrex) Caution: Patients with Hepatic Impairment: In patients with moderate hepatic impairment (Child-Pugh Class II), the recommended daily dose of this product should be reduced by approximately 50%. This product is not recommended for patients with severe hepatic impairment.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles:

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。